Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Forman

Showing results (151-160 of 1,285) with videos related to

Pageof 129
Sort By:
Blut|July 1, 1987
High dose busulfan/etoposide as a preparatory regimen for second bone marrow transplants in hematologic malignanciesK G Blume, S J Forman
Free Radical Biology & Medicine|August 26, 2015
Introduction to Special Issue on 'Nrf2 Regulated Redox Signaling and Metabolism in Physiology and MedicineGiovanni E Mann, Henry J Forman
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1977
Immunogenetic analysis of H-2 mutations. VII. Cells responding to H-2 Kk gene products give rise to an allogeneic supernatantJ Kettman, J Klein, J Forman
Fertility and Sterility|January 2, 2021
An oncofertility prediction tool? Forecasting fertility after cancerPaula C Brady, Eric J Forman
Journal of Cellular Physiology. Supplement|January 1, 1982
Bone marrow transplantation for hematologic malignanciesK G Blume, S J Forman
Transplantation|October 1, 1976
Inability of normal and activated thymus-derived cells to act as cytotoxic effector cells against antibody-coated targetsJ Forman, S Britton, G Möller
Critical Care Clinics|August 30, 2001
Critical care of the hematopoietic stem cell patientD A Horak, S J Forman
Mediterranean Journal of Hematology and Infectious Diseases|March 19, 2011
Allogeneic hematopoietic cell transplantation in the treatment of chronic lymphocytic leukemia: why and when?Maria L Delioukina, Stephen J Forman
Hematology/Oncology Clinics of North America|June 1, 1990
Allogeneic bone marrow transplantation for acute leukemiaS J Forman, K G Blume
Coeur Et Medecine Interne|April 1, 1970
[Antibiotherapy and septic complications in catheterization of left cavities]J Fouchard, J Soulié, J Forman
Pageof 129

Showing results (151-160 of 1,285) with videos related to

Sort By:
Pageof 129
Blut|July 1, 1987
High dose busulfan/etoposide as a preparatory regimen for second bone marrow transplants in hematologic malignanciesK G Blume, S J Forman
Free Radical Biology & Medicine|August 26, 2015
Introduction to Special Issue on 'Nrf2 Regulated Redox Signaling and Metabolism in Physiology and MedicineGiovanni E Mann, Henry J Forman
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1977
Immunogenetic analysis of H-2 mutations. VII. Cells responding to H-2 Kk gene products give rise to an allogeneic supernatantJ Kettman, J Klein, J Forman
Fertility and Sterility|January 2, 2021
An oncofertility prediction tool? Forecasting fertility after cancerPaula C Brady, Eric J Forman
Journal of Cellular Physiology. Supplement|January 1, 1982
Bone marrow transplantation for hematologic malignanciesK G Blume, S J Forman
Transplantation|October 1, 1976
Inability of normal and activated thymus-derived cells to act as cytotoxic effector cells against antibody-coated targetsJ Forman, S Britton, G Möller
Critical Care Clinics|August 30, 2001
Critical care of the hematopoietic stem cell patientD A Horak, S J Forman
Mediterranean Journal of Hematology and Infectious Diseases|March 19, 2011
Allogeneic hematopoietic cell transplantation in the treatment of chronic lymphocytic leukemia: why and when?Maria L Delioukina, Stephen J Forman
Hematology/Oncology Clinics of North America|June 1, 1990
Allogeneic bone marrow transplantation for acute leukemiaS J Forman, K G Blume
Coeur Et Medecine Interne|April 1, 1970
[Antibiotherapy and septic complications in catheterization of left cavities]J Fouchard, J Soulié, J Forman
Pageof 129